BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

217 related articles for article (PubMed ID: 32186702)

  • 1. LHPP suppresses proliferation, migration, and invasion and promotes apoptosis in pancreatic cancer.
    Wu F; Chen Y; Zhu J
    Biosci Rep; 2020 Mar; 40(3):. PubMed ID: 32186702
    [TBL] [Abstract][Full Text] [Related]  

  • 2. As a Novel Tumor Suppressor, LHPP Promotes Apoptosis by Inhibiting the PI3K/AKT Signaling Pathway in Oral Squamous Cell Carcinoma.
    Liu S; Gao W; Lu Y; Zhou Q; Su R; Hasegawa T; Du J; Li M
    Int J Biol Sci; 2022; 18(2):491-506. PubMed ID: 35002505
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Down-regulation of LHPP in cervical cancer influences cell proliferation, metastasis and apoptosis by modulating AKT.
    Zheng J; Dai X; Chen H; Fang C; Chen J; Sun L
    Biochem Biophys Res Commun; 2018 Sep; 503(2):1108-1114. PubMed ID: 29944886
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tumor suppressor LHPP regulates the proliferation of colorectal cancer cells via the PI3K/AKT pathway.
    Hou B; Li W; Li J; Ma J; Xia P; Liu Z; Zeng Q; Zhang X; Chang D
    Oncol Rep; 2020 Feb; 43(2):536-548. PubMed ID: 31894339
    [TBL] [Abstract][Full Text] [Related]  

  • 5. IGF-1 mediates PTEN suppression and enhances cell invasion and proliferation via activation of the IGF-1/PI3K/Akt signaling pathway in pancreatic cancer cells.
    Ma J; Sawai H; Matsuo Y; Ochi N; Yasuda A; Takahashi H; Wakasugi T; Funahashi H; Sato M; Takeyama H
    J Surg Res; 2010 May; 160(1):90-101. PubMed ID: 19560785
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Purpurin binding interacts with LHPP protein that inhibits PI3K/AKT phosphorylation and induces apoptosis in colon cancer cells HCT-116.
    Li Z; Zhou X; Zhu H; Song X; Gao H; Niu Z; Lu J
    J Biochem Mol Toxicol; 2021 Mar; 35(3):e22665. PubMed ID: 33368780
    [TBL] [Abstract][Full Text] [Related]  

  • 7. LHPP inhibits cell growth and migration and triggers autophagy in papillary thyroid cancer by regulating the AKT/AMPK/mTOR signaling pathway.
    Sun W; Qian K; Guo K; Chen L; Xiang J; Li D; Wu Y; Ji Q; Sun T; Wang Z
    Acta Biochim Biophys Sin (Shanghai); 2020 Apr; 52(4):382-389. PubMed ID: 32227107
    [TBL] [Abstract][Full Text] [Related]  

  • 8. LHPP suppresses proliferation, migration, and invasion in hepatocellular carcinoma and pancreatic cancer by inhibiting EGFR signaling pathway.
    Zhu H; Song C; Li J; Liu Q; Liu M; Fu L
    Med Oncol; 2023 Jul; 40(9):257. PubMed ID: 37522936
    [TBL] [Abstract][Full Text] [Related]  

  • 9. LHPP suppresses bladder cancer cell proliferation and growth via inactivating AKT/p65 signaling pathway.
    Li Y; Zhang X; Zhou X; Zhang X
    Biosci Rep; 2019 Jul; 39(7):. PubMed ID: 31262971
    [TBL] [Abstract][Full Text] [Related]  

  • 10. CBX7 suppresses cell proliferation, migration, and invasion through the inhibition of PTEN/Akt signaling in pancreatic cancer.
    Ni S; Wang H; Zhu X; Wan C; Xu J; Lu C; Xiao L; He J; Jiang C; Wang W; He Z
    Oncotarget; 2017 Jan; 8(5):8010-8021. PubMed ID: 28030829
    [TBL] [Abstract][Full Text] [Related]  

  • 11. PLS3 predicts poor prognosis in pancreatic cancer and promotes cancer cell proliferation via PI3K/AKT signaling.
    Xin Z; Li D; Mao F; Du Y; Wang X; Xu P; Li Z; Qian J; Yao J
    J Cell Physiol; 2020 Nov; 235(11):8416-8423. PubMed ID: 32239705
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Alpha1-ACT Functions as a Tumour Suppressor in Hepatocellular Carcinoma by Inhibiting the PI3K/AKT/mTOR Signalling Pathway via Activation of PTEN.
    Zhu H; Liu Q; Tang J; Xie Y; Xu X; Huang R; Zhang Y; Jin K; Sun B
    Cell Physiol Biochem; 2017; 41(6):2289-2306. PubMed ID: 28456796
    [TBL] [Abstract][Full Text] [Related]  

  • 13. MicroRNA-106b promotes pituitary tumor cell proliferation and invasion through PI3K/AKT signaling pathway by targeting PTEN.
    Zhou K; Zhang T; Fan Y; Serick ; Du G; Wu P; Geng D
    Tumour Biol; 2016 Oct; 37(10):13469-13477. PubMed ID: 27465551
    [TBL] [Abstract][Full Text] [Related]  

  • 14. (‑)‑Epigallocatechin‑3‑gallate induces apoptosis in human pancreatic cancer cells via PTEN.
    Liu S; Xu ZL; Sun L; Liu Y; Li CC; Li HM; Zhang W; Li CJ; Qin W
    Mol Med Rep; 2016 Jul; 14(1):599-605. PubMed ID: 27176210
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Metastasis suppressor protein 1 regulated by PTEN suppresses invasion, migration, and EMT of gastric carcinoma by inactivating PI3K/AKT signaling.
    Wang H; Zhao Y; Cao L; Zhang J; Wang Y; Xu M
    J Cell Biochem; 2019 Mar; 120(3):3447-3454. PubMed ID: 30246429
    [TBL] [Abstract][Full Text] [Related]  

  • 16. MiR-4299 suppresses non-small cell lung cancer cell proliferation, migration and invasion through modulating PTEN/AKT/PI3K pathway.
    Yang WB; Zhang WP; Shi JL; Wang JW
    Eur Rev Med Pharmacol Sci; 2018 Jun; 22(11):3408-3414. PubMed ID: 29917192
    [TBL] [Abstract][Full Text] [Related]  

  • 17. PMEPA1 interference activates PTEN/PI3K/AKT, thereby inhibiting the proliferation, invasion and migration of pancreatic cancer cells and enhancing the sensitivity to gemcitabine and cisplatin.
    Yang Y; Cheng T; Xie P; Wang L; Chen H; Cheng Z; Zhou J
    Drug Dev Res; 2022 Feb; 83(1):64-74. PubMed ID: 34189738
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The histidine phosphatase LHPP: an emerging player in cancer.
    Wu F; Ma H; Wang X; Wei H; Zhang W; Zhang Y
    Cell Cycle; 2022 Jun; 21(11):1140-1152. PubMed ID: 35239447
    [TBL] [Abstract][Full Text] [Related]  

  • 19. EG-VEGF silencing inhibits cell proliferation and promotes cell apoptosis in pancreatic carcinoma via PI3K/AKT/mTOR signaling pathway.
    Yan X; Hui Y; Hua Y; Huang L; Wang L; Peng F; Tang C; Liu D; Song J; Wang F
    Biomed Pharmacother; 2019 Jan; 109():762-769. PubMed ID: 30551529
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Polycomb complex protein BMI-1 promotes invasion and metastasis of pancreatic cancer stem cells by activating PI3K/AKT signaling, an ex vivo, in vitro, and in vivo study.
    Wang MC; Jiao M; Wu T; Jing L; Cui J; Guo H; Tian T; Ruan ZP; Wei YC; Jiang LL; Sun HF; Huang LX; Nan KJ; Li CL
    Oncotarget; 2016 Feb; 7(8):9586-99. PubMed ID: 26840020
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.